ATE381577T1 - Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma - Google Patents
Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasmaInfo
- Publication number
- ATE381577T1 ATE381577T1 AT97935986T AT97935986T ATE381577T1 AT E381577 T1 ATE381577 T1 AT E381577T1 AT 97935986 T AT97935986 T AT 97935986T AT 97935986 T AT97935986 T AT 97935986T AT E381577 T1 ATE381577 T1 AT E381577T1
- Authority
- AT
- Austria
- Prior art keywords
- apolipoprotein
- apoe
- apoa
- human plasma
- atherosclerosis
- Prior art date
Links
- 102100029470 Apolipoprotein E Human genes 0.000 title abstract 7
- 101710095339 Apolipoprotein E Proteins 0.000 title abstract 7
- 238000000034 method Methods 0.000 title abstract 3
- 201000001320 Atherosclerosis Diseases 0.000 abstract 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract 2
- 206010040047 Sepsis Diseases 0.000 abstract 2
- 238000005571 anion exchange chromatography Methods 0.000 abstract 2
- 230000002093 peripheral effect Effects 0.000 abstract 2
- 102000007592 Apolipoproteins Human genes 0.000 abstract 1
- 108010071619 Apolipoproteins Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9603068A SE9603068D0 (sv) | 1996-08-23 | 1996-08-23 | Process for purifying a protein |
| US2538796P | 1996-09-04 | 1996-09-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE381577T1 true ATE381577T1 (de) | 2008-01-15 |
Family
ID=26662734
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97935986T ATE381577T1 (de) | 1996-08-23 | 1997-08-22 | Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0934337B1 (de) |
| JP (1) | JP2001522349A (de) |
| AT (1) | ATE381577T1 (de) |
| AU (1) | AU731021B2 (de) |
| CA (1) | CA2274241C (de) |
| DE (1) | DE69738397D1 (de) |
| WO (1) | WO1998007751A1 (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6306433B1 (en) | 1997-08-12 | 2001-10-23 | Pharmacia Ab | Method of preparing pharmaceutical compositions |
| US7205280B2 (en) * | 1998-03-11 | 2007-04-17 | Cognosci, Inc. | Methods of suppressing microglial activation |
| DE19963420A1 (de) * | 1999-12-28 | 2001-07-12 | Sebo Gmbh | Gewinnung von biologischen Komponenten aus Körperflüssigkeiten |
| ES2219517T3 (es) * | 2000-03-03 | 2004-12-01 | Glaxosmithkline Biologicals S.A. | Vacuna para el tratamiento de la aterosclerosis. |
| NZ582170A (en) | 2007-08-17 | 2012-02-24 | Csl Behring Gmbh | Methods for purification of alpha-1-antitrypsin and apolipoprotein a-i |
| EP2305309A2 (de) | 2008-06-13 | 2011-04-06 | Proyecto de Biomedicina Cima, S.L. | Konjugate zur verabreichung von biologischen wirkstoffen |
| CN102127165B (zh) * | 2010-01-15 | 2013-09-04 | 上海莱士血液制品股份有限公司 | 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺 |
| JP6404333B2 (ja) | 2013-06-05 | 2018-10-10 | シーエスエル、リミテッド | アポリポタンパク質ａ−ｉ（アポａ−ｉ）の製造方法 |
| CN107033237B (zh) * | 2017-05-11 | 2021-07-20 | 深圳市卫光生物制品股份有限公司 | 一种人血浆载脂蛋白a-i的分离纯化方法 |
| CN110590937A (zh) * | 2018-06-13 | 2019-12-20 | 杨宝田 | 一种人血载脂蛋白a1制品的制备方法及应用 |
| EP3917943A4 (de) * | 2019-02-01 | 2022-12-07 | Ohio State Innovation Foundation | Verfahren zur reinigung von proteinen |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA1335077C (en) * | 1988-02-08 | 1995-04-04 | Henri Isliker | Process for the manufacture of apolipoproteins from human blood plasma or serum |
-
1997
- 1997-08-22 CA CA002274241A patent/CA2274241C/en not_active Expired - Fee Related
- 1997-08-22 WO PCT/SE1997/001393 patent/WO1998007751A1/en not_active Ceased
- 1997-08-22 JP JP51066598A patent/JP2001522349A/ja not_active Ceased
- 1997-08-22 DE DE69738397T patent/DE69738397D1/de not_active Expired - Lifetime
- 1997-08-22 AT AT97935986T patent/ATE381577T1/de not_active IP Right Cessation
- 1997-08-22 EP EP97935986A patent/EP0934337B1/de not_active Expired - Lifetime
- 1997-08-22 AU AU38762/97A patent/AU731021B2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| DE69738397D1 (de) | 2008-01-31 |
| JP2001522349A (ja) | 2001-11-13 |
| WO1998007751A1 (en) | 1998-02-26 |
| AU731021B2 (en) | 2001-03-22 |
| CA2274241C (en) | 2003-05-27 |
| CA2274241A1 (en) | 1998-02-26 |
| AU3876297A (en) | 1998-03-06 |
| EP0934337A1 (de) | 1999-08-11 |
| EP0934337B1 (de) | 2007-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE9603068D0 (sv) | Process for purifying a protein | |
| DE69736712D1 (de) | Verfahren zur milderung von neuropatischen schmerz mit prosaposin verwandten peptiden | |
| UA66745C2 (en) | INTERLEUKIN-1b-CONVERTING ENZYME INHIBITORS, PHARMACEUTICAL COMPOSITION AND A METHOD FOR TREATMENT OF DISEASES | |
| UA39135C2 (uk) | Спосіб фракціонування розчину | |
| DE69629949D1 (de) | Aktivierte verbindungen und verfahren zur herstellung und reiningung | |
| DE69738397D1 (de) | Verfahren zur aufreinigung von apolipoprotein-a oder apolipoprotein-e aus menschlichem plasma | |
| ATE225368T1 (de) | Verfahren zur reinigung von faktor viii | |
| DE59409712D1 (de) | Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen | |
| EP0785785A4 (de) | Verfahren zur bekämpfung von mit neuropeptiden zusammenhängenden erkrankungen | |
| PT813541E (pt) | Processo de producao de uma proteina | |
| DK1003546T3 (da) | Fremgangsmåde til behandling af patienter ramt af dissemineret sklerose ved anvendelse af konsensus interferon | |
| DE69632887D1 (de) | Verfahren zur zweckmässige Herstellung von Transglutaminase durch DNA-Rekombination | |
| ATE448795T1 (de) | Methode zur behandlung von wundheilung in diabetikern | |
| DK1049767T3 (da) | En transgen kanin, der udtrykker et funktionelt humant lipoprotein(A) | |
| DE69434937D1 (de) | Verfahren zur Herstellung von Leistungsbauteilen in MOS-Technologie | |
| ATE206158T1 (de) | Verfahren zur herstellung von gereinigtem enzym | |
| DE59704288D1 (de) | Verfahren zur Herstellung von Alpha,Omega-C4- bis C20-Alkenolen | |
| ATE240743T1 (de) | Verfahren und substanzen gegen protozoen | |
| DE69531308D1 (de) | Verfahren zur Herstellung von gereinigten papillomavirus Proteinen | |
| DE69502119D1 (de) | Verfahren zur Herstellung von vorgespannten Kugelumlaufspindeln | |
| ATE131490T1 (de) | Verfahren zur herstellung von gereinigten albuminlösungen | |
| ATE347564T1 (de) | Verfahren zur reinigung von hämoglobin | |
| ATE251886T1 (de) | Verwendunf von apoe zum binden von tau und map2c proteinen und zur behandlung von alzheimer's krankheit | |
| SE9603304D0 (sv) | Process for purifying a compound | |
| DE69902639D1 (de) | Verbessertes verfahren zur herstellung von faktor viii |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |